NCT05713513View on ClinicalTrials.gov

Manufacture of Clinical T-cell Products for Future Treatment

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

July 24, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Virus-specific T Cells
Interventions
OTHER

Leukapheresis

Leukapheresis to isolate 1x10e9 cells, examined for purity and specificity under Good Manufacturing Practice (GMP)

Trial Locations (1)

4031

University Hospital Basel, Departement Infektiologie & Spitalhygiene, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT05713513 - Manufacture of Clinical T-cell Products for Future Treatment | Biotech Hunter | Biotech Hunter